When was Swift Biosciences founded?

Swift Biosciences was founded in 2010 and raised its 1st funding round within a year of its incorporation.

Where is Swift Biosciences located?

Swift Biosciences is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan.

Who is the current CEO of Swift Biosciences?

Timothy Harkins of Swift Biosciences.

How many employees does Swift Biosciences have?

As of Dec 31, 2022, Swift Biosciences has 41 employees, reflecting a 2% year-over-year decline in headcount.

Is Swift Biosciences a funded company?

Swift Biosciences is a funded company, having raised a total of $35.2M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 2010.

When was the latest funding round of Swift Biosciences?

Swift Biosciences' latest funding was a $***** Series D round on Nov 01, 2018, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does Swift Biosciences rank among its competitors?

Swift Biosciences ranks 122nd amongst 1099 active competitors, of which 84 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Huwel Life, which secured $5.64M in Sep, 2025.

Who are the top competitors of Swift Biosciences?

Swift Biosciences' top competitors include Abcam, Meridian Bioscience and LGC. Among them, Huwel Life secured the most recent funding round in September, 2025.

Swift Biosciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Swift Biosciences is developing new methods and technologies for sample and library prep for next generation sequencing. It offers Accel-NGS DNA library kits ( Illumina NGS & Ion-Torrent platforms) which are designed to accelerate sample preparation for DNA sequencing and deliver more usable data from NGS instruments; Accel-Amplicon Panels for detecting and screening clinically relevant mutations. It also offers myT Primers used in quantitative polymerase chain reaction (qPCR) detection of key cancer mutations.

Website: swiftbiosci.com
Social
Registered Address: Ann Arbor, Michigan

Key Metrics

Founded Year

2010

Location

Ann Arbor, United States

Stage

Acqui-Hired

Total Funding

$35.2M in 10 rounds

Latest Funding Round

Series D, Nov 01, 2018, $*****

Investors

Arboretum Ventures & 4 more

Ranked

122^nd among 1099 active competitors

Employee Count

41 as on Dec 31, 2022

Similar Companies

LGC & 415 more

View Swift Biosciences' full profile

Swift Biosciences is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Swift Biosciences, Inc. CIN: 270670569 , United States, Active	Dec 26, 999	-	41 (As on Dec 31, 2020)	-

Swift Biosciences has raised a total funding of $35.2M over 10 rounds. Its first funding round was on Jan 2010. Swift Biosciences has 5 institutional investors.

Here is the list of recent funding rounds of Swift Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 01, 2018	9692614	Series D	8751583	9532652	3729328	5609071
Jun 12, 2017	8606497	Series D	3828412	5822716	1021218	9209364
Jan 27, 2017	6233691	Series C	3121873	6147355	4072665	6844601

Access funding benchmarks and valuations. Sign up today!

View details of Swift Biosciences's funding rounds and investors

Swift Biosciences' employee count trend

Swift Biosciences has 41 employees as of Dec 22. The total employee count is 2.0% lower than what it was in Dec 21. Here is Swift Biosciences's employee count trend over the years:

Employee count trend for Swift Biosciences

Uncover Swift Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Swift Biosciences include Abcam, Meridian Bioscience and LGC. Here is the list of Top 10 competitors of Swift Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	LGC 1842, Teddington (United Kingdom), Acquired	Provider of analytical testing, reference materials, and diagnostic and therapeutic products	-	Broad Vision Funds, AlpInvest Partners & 4 others	65/100
4th	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
5th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
6th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
7th	seqWell 2014, Beverly (United States), Series C	Provider of NGS-based reagents and kits for life sciences research	$24.5M	RCT, Codexis & 3 others	60/100
8th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
9th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
10th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
122nd	Swift Biosciences 2010, Ann Arbor (United States), Acqui-Hired	Develops and sells reagents for genetic testing and Next Generation Sequencing (NGS).	$35.2M	Arboretum Ventures, Charter Capital Partners ... & 3 others	36/100